Press release
Neurodegenerative Disease Market Report Analysis, Research Studies, Growth Forecast: Teva Pharmaceutical, UCB SA and Novartis.
DataM Intelligence
Get a Free Sample PDF - https://datamintelligence.com/download-sample/neurodegenerative-disease-market
What is the projected growth rate (CAGR) of the Global Neurodegenerative Disease market from 2024 to 2031, and what is the market value expected to change by 2031?
The Neurodegenerative Disease Market is expected to grow at a CAGR of 7.45% during the forecast period 2024-2031
What is Neurodegenerative Disease Market?
Neurodegenerative diseases are a group of disorders characterized by the gradual deterioration of nerve cells (neurons) in the brain and spinal cord, leading to progressive loss of function in movement, cognition, and other neurological functions. These diseases include Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis (ALS), each affecting different regions of the nervous system with distinct symptoms. While the exact causes vary, they often involve genetic, environmental, and lifestyle factors that lead to abnormal protein accumulation and neuron damage. Currently, most neurodegenerative diseases have no cure, but ongoing research aims to develop treatments that slow progression, improve quality of life, and potentially reverse damage.
Who are the major players in the Neurodegenerative Disease market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Neurodegenerative Disease market research report are: AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, UCB SA and Novartis.
Key Development
On 16 August 2022, GSK acquired Affinivax, Inc.
Also, in May 2022, Pfizer agreed to acquire Biohaven.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=neurodegenerative-disease-market
Regions Covered:
The global Neurodegenerative Disease Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Market Segments
By Indication Type (Parkinson's Disease, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Huntington Disease, Others)
By Drug Type (N-methyl-D-aspartate Receptor, Selective Serotonin Reuptake Inhibitor, the Dopamine Inhibitors, Others)
By End-User (Hospitals, Clinics, Others)
The Neurodegenerative Disease industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Neurodegenerative Disease industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Neurodegenerative Disease innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Neurodegenerative Disease market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Neurodegenerative Disease
➥ Maximize market presence with brand share analysis, strengthening your position in the Neurodegenerative Disease landscape.
➥ Accurately predict market demand for Neurodegenerative Disease with precise drug sales forecasting insights.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/neurodegenerative-disease-market
FAQs
What does the Neurodegenerative Disease market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Neurodegenerative Disease market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurodegenerative Disease Market Report Analysis, Research Studies, Growth Forecast: Teva Pharmaceutical, UCB SA and Novartis. here
News-ID: 3711336 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Future of Micro-Mobility Market: Green Mobility & Mobility-as-a-Service (MaaS) | …
Global Micro-Mobility Market reached US$ 3.6 Billion in 2023 and is expected to reach US$ 9.0 Billion by 2031, growing with a CAGR of 12.1% during the forecast period 2024-2031.
The Micro-Mobility Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative product offerings,…
Future of Conductive Textile Market Growth & Why VCs Are Paying Attention
DataM Intelligence has published a new research report on "Conductive Textile Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get…
Panelized Modular Building Systems Market Gains Momentum as Investors Bet on Eff …
DataM Intelligence has published a new research report on "Panelized Modular Building Systems Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Asia-Pacific is set to dominate the…
Fenoxaprop P Ethyl Herbicide Market Outlook: Crop Protection Innovation | Major …
Global Fenoxaprop P Ethyl Market reached US$ 202.87 million in 2022 and is expected to reach US$ 308.98 million by 2031, growing with a CAGR of 5.4% during the forecast period 2024-2031.
The Fenoxaprop P Ethyl Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
